ECT and Ethical Psychiatry
American Journal of Psychiatry 1977 September; 134(9): 1006-1009
Showing items related by title, author, creator and subject.
Salzman, Carl (1977-09)
Salzman, Carl (1990-09-20)The U.S. Food and Drug Administration requires that the administration of clozapine, a promising neuroleptic drug, be linked with frequent blood screening to detect a potentially toxic effect. The drug's manufacturer has ...
Suicidality and Risk of Suicide -- Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement Meyer, Roger E; Salzman, Carl; Youngstrom, Eric A; Clayton, Paula J; Goodwin, Frederick K; Mann, J John; Alphs, Larry D; Broich, Karl; Goodman, Wayne K; Greden, John F; Meltzer, Herbert Y; Normand, Sharon-Lise T; Posner, Kelly; Shaffer, David; Oquendo, Maria A; Stanley, Barbara; Trivedi, Madhukar H; Turecki, Gustavo; Beasley, Charles M Jr.; Beautrais, Annette L; Bridge, Jeffrey A; Brown, Gregory K; Revicki, Dennis A; Ryan, Neal D; Sheehan, David V (2010-08)OBJECTIVE: To address issues concerning potential treatment-emergent "suicidality," a consensus conference was convened March 23-24, 2009. PARTICIPANTS: This gathering of participants from academia, government, and industry ...